A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

A phase 3 clinical trial has demonstrated that daraxonrasib significantly improved overall survival and progression-free ...

A first-of-its-kind study of breast cancer in Native women found that their tumors may respond differently to treatment than those of white women. Native women have breast cancer at lower rates than ...

A major clinical trial is offering new hope for patients battling one of the deadliest forms of cancer.

OSF HealthCare Cancer Institute has launched a new website listing open clinical trials. The page is here, according to a ...

Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the European Research Council (ERC), have identified a 14-protein signature in the ...

There’s new hope for one of the world’s deadliest cancers. Groundbreaking clinical trial results show that an experimental ...

WASHINGTON (AP) — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, ...

Lung cancer may not be the most common cancer diagnosis in the United States—that would be prostate cancer for men and breast ...

For much of his life, Christopher Musati wanted nothing to do with hospitals. Growing up, the 34-year-old Butler resident watched a close family member battle a rare disease, an experience that left ...

Integris Health Cancer Institute will host a National Cancer Survivors Day event at Scissortail Park in Oklahoma City to honor survivors and support families.